Bayer
Bayer AG, a global leader in the life sciences sector, is headquartered in Leverkusen, Germany. Founded in 1863, Bayer has established itself as a prominent player in the pharmaceutical, consumer health, and agricultural industries. The company operates extensively across Europe, North America, and Asia, providing innovative solutions that enhance health and nutrition. Bayer's core offerings include prescription medications, over-the-counter products, and crop science solutions, distinguished by their commitment to research and development. Notable achievements include the development of groundbreaking treatments and sustainable agricultural practices, positioning Bayer as a trusted name in health and agriculture. With a strong market presence and a dedication to improving lives, Bayer continues to drive advancements that benefit society globally.
DitchCarbon Score
How does Bayer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer's score of 72 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bayer's reported carbon emissions
In 2023, Bayer reported total greenhouse gas emissions of approximately 12,200,000,000 kg CO2e, comprising 1,890,000,000 kg CO2e from Scope 1, 940,000,000 kg CO2e from Scope 2, and 9,180,000,000 kg CO2e from Scope 3 emissions. This reflects Bayer's ongoing commitment to sustainability and climate action. Bayer has set ambitious targets to reduce its carbon footprint. The company aims to achieve net-zero greenhouse gas emissions across its entire value chain by 2050. In the near term, Bayer has committed to reducing absolute Scope 1 and 2 emissions by 42% by 2029, using 2019 as the baseline year. Additionally, Bayer plans to cut Scope 3 emissions by 25% within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit temperature rise to 1.5°C. Bayer's long-term goal includes a 90% reduction in absolute emissions across all scopes by 2050, further demonstrating its commitment to environmental stewardship and sustainable practices in the pharmaceutical and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2008 | 2009 | 2010 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 5,090,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 3,570,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bayer is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
